An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB, Seeff LB. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54(4):1433-1444.

Publication Type:

Journal Article

Authors:

Ghany, M.G.; David R. Nelson; Strader, D.B.; Thomas, D.L.; Seeff, L.B.; American Association for Study of Liver Diseases

Source:

Hepatology, Volume 54, Issue 4, p.1433-1444 (2011)

Keywords:

analogs & derivatives, Antiviral Agents, Comparative Study, Disease, drug effects, Drug Resistance,Viral, drug therapy, Female, genetics, Genotype, Health, Hepacivirus, hepatitis, Hepatitis C, Hepatitis C,Chronic, Humans, Infection, Kidney, Kidney Diseases, Liver, Liver Diseases, Male, Oligopeptides, physiopathology, Prognosis, Proline, Protease Inhibitors, Randomized Controlled Trials as Topic, Recurrence, Risk Assessment, Societies,Medical, standards, Telaprevir, therapeutic use, Treatment Outcome, United States

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/21898493

Export Citation:

RIS Format

Top